Table 2. Analysis of Association between HSPA1A Polymorphisms and Risk of CHD in a Chinese population.

Genotype	Cases		Controls		Crude OR (95% CI)	Adjusted OR (95% CI)*
	n	%	n	%
+190G/C
GG	434	44.2	479	47.8	1.00	1.00
GC	416	42.4	415	41.4	1.11(0.92–1.34)	1.04(0.83–1.31)
CC	131	13.4	109	10.8	1.33(1.00–1.77)†	1.56(1.10–2.20)‡
GC+CC	547	55.8	524	52.2	1.15(0.97–1.38)	1.13(0.91–1.40)
−110A/C
AA	317	32.3	350	34.9	1.00	1.00
AC	476	48.6	472	47.1	1.11(0.91–1.36)	1.15(0.90–1.46)
CC	187	19.1	181	18.0	1.14(0.88–1.47)	1.17(0.86–1.60)
AC+CC	663	67.7	653	65.1	1.12(0.93–1.35)	1.14(0.91–1.43)

^*Adjusted for age, sex, pack-year of smoking, drinking, activity, hypertension, DM and family history of CHD. Compared with GG genotype.

^† P = 0.052 and

^‡ P = 0.012, respectively.